ADAMTS9 is a novel cancer regulator that has been reported to be involved in a variety of cancers, such as gastric cancer [32], liver cancer [33], breast cancer [34], prostate cancer [35], and bladder cancer [36]. This evidence concerns the gene ADAMTS9 and breast carcinoma.